share_log

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RYAN ARTHUR F

SEC ·  Jan 7 05:15

Summary by Moomoo AI

On January 2, 2025, RYAN ARTHUR F, an executive at Regeneron Pharmaceuticals, was granted 166 shares of Common Stock at $0 per share. This transaction was reported as a direct acquisition under the transaction code 'A', indicating a grant, award, or other acquisition.Following this transaction, RYAN ARTHUR F's direct ownership of Regeneron Pharmaceuticals Common Stock increased to 17,748 shares. The acquisition was completed on the reported date, with no additional transactions mentioned in the filing.
On January 2, 2025, RYAN ARTHUR F, an executive at Regeneron Pharmaceuticals, was granted 166 shares of Common Stock at $0 per share. This transaction was reported as a direct acquisition under the transaction code 'A', indicating a grant, award, or other acquisition.Following this transaction, RYAN ARTHUR F's direct ownership of Regeneron Pharmaceuticals Common Stock increased to 17,748 shares. The acquisition was completed on the reported date, with no additional transactions mentioned in the filing.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Sana Biotechnology
    SANA
    -- 4.300
    Vir Biotechnology
    VIR
    -- 12.480
    Silo Pharma
    SILO
    -- 1.710
    Compass Therapeutics
    CMPX
    -- 1.860
    NLS Pharmaceutics
    NLSP
    -- 2.4100

    Unlock the Full List